These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9893422)

  • 21. New-onset seizures: a possible association with clonidine?
    Feron FJ; Hendriksen JG; Nicolai J; Vles JS
    Pediatr Neurol; 2008 Feb; 38(2):147-9. PubMed ID: 18206800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine aspects of attention deficit hyperactivity disorder.
    Jensen JB; Garfinkel BD
    Neurol Clin; 1988 Feb; 6(1):111-29. PubMed ID: 3380074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of clonidine in children with autism spectrum disorders.
    Ming X; Gordon E; Kang N; Wagner GC
    Brain Dev; 2008 Aug; 30(7):454-60. PubMed ID: 18280681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How should we evaluate and treat ADHD in children and adolescents?
    Ambalavanan G; Holten KB
    J Fam Pract; 2005 Dec; 54(12):1058-9. PubMed ID: 16321344
    [No Abstract]   [Full Text] [Related]  

  • 25. Intranasal clonidine as a premedicant: three cases with unique indications.
    Stella MJ; Bailey AG
    Paediatr Anaesth; 2008 Jan; 18(1):71-3. PubMed ID: 18095969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder.
    Biederman J
    J Clin Psychiatry; 2006; 67 Suppl 8():4-6. PubMed ID: 16961423
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders.
    Du YS; Li HF; Vance A; Zhong YQ; Jiao FY; Wang HM; Wang MJ; Su LY; Yu DL; Ma SW; Wu JB
    Aust N Z J Psychiatry; 2008 Sep; 42(9):807-13. PubMed ID: 18696285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME; Lapane KL
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indications for clonidine in child psychiatry].
    Dollfus S
    Encephale; 1993; 19(2):83-7. PubMed ID: 8275901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yohimbine as an antidote for clonidine overdose.
    Roberge RJ; McGuire SP; Krenzelok EP
    Am J Emerg Med; 1996 Nov; 14(7):678-80. PubMed ID: 8906769
    [No Abstract]   [Full Text] [Related]  

  • 32. [Attention deficit disorders with hyperactivity in adulthood; implications for diagnosis and treatment].
    Kooij JJ; Goekoop JG; Gunning WB
    Ned Tijdschr Geneeskd; 1996 Sep; 140(37):1848-51. PubMed ID: 8927155
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
    Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
    Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased use of clonidine following treatment with atomoxetine in children with ADHD.
    Johnston JA; Ye W; Van Brunt DL; Pohl G; Sumner CR
    J Clin Psychopharmacol; 2006 Aug; 26(4):389-95. PubMed ID: 16855457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonidine treatment of hyperactive and impulsive children with autistic disorder.
    Jaselskis CA; Cook EH; Fletcher KE; Leventhal BL
    J Clin Psychopharmacol; 1992 Oct; 12(5):322-7. PubMed ID: 1479049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One hundred times the intended dose of caudal clonidine in three pediatric patients.
    Meyer C; Cambray R
    Paediatr Anaesth; 2008 Sep; 18(9):888-90. PubMed ID: 18482242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal methylphenidate system: old wine in a new bottle.
    Bukstein OG
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating attention-deficit/hyperactivity disorder with a stimulant transdermal patch: the clinical art.
    Arnold LE; Lindsay RL; López FA; Jacob SE; Biederman J; Findling RL; Ramadan Y
    Pediatrics; 2007 Nov; 120(5):1100-6. PubMed ID: 17974748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
    Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A
    Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder.
    Ibrahim el SR
    Hum Psychopharmacol; 2002 Jul; 17(5):225-31. PubMed ID: 12404679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.